PARP16
Protein mono-ADP-ribosyltransferase PARP16
Also known as: ARTD15, C15orf30, FLJ20509, FLJ25281, PAR16_HUMAN, pART15
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N5Y8
- Gene
- PARP16
- Ensembl
- ENSG00000138617
- Chromosome
- 15
- Canonical length
- 322 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins
OverviewNCBI Gene
Enables kinase binding activity; pentosyltransferase activity; and protein serine/threonine kinase activator activity. Involved in IRE1-mediated unfolded protein response; negative regulation of cytoplasmic translation; and protein auto-ADP-ribosylation. Located in endoplasmic reticulum tubular network and nuclear envelope. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
322 residues, UniProt reviewed canonical sequence.
>Q8N5Y8|PARP16
1 MQPSGWAAAR EAAGRDMLAA DLRCSLFASA LQSYKRDSVL RPFPASYARG DCKDFEALLA
61 DASKLPNLKE LLQSSGDNHK RAWDLVSWIL SSKVLTIHSA GKAEFEKIQK LTGAPHTPVP
121 APDFLFEIEY FDPANAKFYE TKGERDLIYA FHGSRLENFH SIIHNGLHCH LNKTSLFGEG
181 TYLTSDLSLA LIYSPHGHGW QHSLLGPILS CVAVCEVIDH PDVKCQTKKK DSKEIDRRRA
241 RIKHSEGGDI PPKYFVVTNN QLLRVKYLLV YSQKPPKRAS SQLSWFSSHW FTVMISLYLL
301 LLLIVSVINS SAFQHFWNRA KRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PARP16 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- liver: 13 nTPM
- ovary: 11 nTPM
- cervix: 11 nTPM
- urinary bladder: 9.7 nTPM
- colon: 9.6 nTPM
- thymus: 9.4 nTPM
Single-cell type
- rod photoreceptor cells: 132 nCPM
- oocytes: 101 nCPM
- differentiating spermatogonia: 89 nCPM
- undifferentiated spermatogonia: 73 nCPM
- retinal bipolar cells: 56 nCPM
- adrenal cortex cells: 44 nCPM
Immune cell
- basophil: 20 nTPM
- neutrophil: 15 nTPM
- naive CD4 T-cell: 15 nTPM
- MAIT T-cell: 14 nTPM
- memory CD8 T-cell: 13 nTPM
- gdT-cell: 13 nTPM
Brain region
- cerebellum: 9.5 nTPM
- cerebral cortex: 5.8 nTPM
- white matter: 5.6 nTPM
- basal ganglia: 5.4 nTPM
- hypothalamus: 5.3 nTPM
- amygdala: 5.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.48
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.37
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to leukemia inhibitory factor
- endoplasmic reticulum unfolded protein response
- IRE1-mediated unfolded protein response
- negative regulation of cytoplasmic translation
- nicotinate metabolic process
- protein auto-ADP-ribosylation
- viral protein processing
Molecular functions
- kinase binding
- NAD+ poly-ADP-ribosyltransferase activity
- NAD+-protein mono-ADP-ribosyltransferase activity
- NAD+-protein-aspartate ADP-ribosyltransferase activity
- NAD+-protein-glutamate ADP-ribosyltransferase activity
- NAD+-protein-lysine ADP-ribosyltransferase activity
- nucleotidyltransferase activity
- protein serine/threonine kinase activator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Poly(ADP-ribose) polymerase, catalytic domain
- Intracellular mono-ADP-ribosyltransferase ARTD/PARP
- Poly(ADP-ribose) polymerase catalytic domain
- PARP16 N-terminal domain
- ARTD15 N-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PARP16 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PARP16 as an antibody target. Whether an autoantibody or antibody against PARP16 could matter depends on whether native PARP16 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PARP16 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PARP16 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...